NanoLuc reporter for dual luciferase imaging in living animals

Molecular Imaging

Volumn 12, Issue 7, 2013, Pages

  Stacer, Amanda C ^a   Nyati, Shyam ^a   Moudgil, Pranav ^a   Iyengar, Rahul ^a   Luker, Kathryn E ^a   Rehemtulla, Alnawaz ^a   Luker, Gary D ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINETRIPHOSPHATE; ANIMALS; BACTERIOPHAGES; BIOLUMINESCENCE; CELL SIGNALING; ENZYMES; HISTOLOGY; MAMMALS; PHOSPHORESCENCE; PLANTS (BOTANY); SIGNAL TRANSDUCTION; TISSUE;

BIOLUMINESCENCE IMAGING; BIOMEDICAL RESEARCH; CELL-BASED ASSAYS; DRUG DEVELOPMENT; FIREFLY LUCIFERASE; FLUORESCENCE IMAGING; LUCIFERASE ENZYMES; TRANSFORMING GROWTH FACTOR-B;

MOLECULAR IMAGING;

COELENTERAZINE; FIREFLY LUCIFERASE; IMIDAZOLE DERIVATIVE; LUCIFERASE; PYRAZINE DERIVATIVE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL; BREAST TUMOR; CANCER TRANSPLANTATION; CELL LINE; DISEASE COURSE; ENZYME SPECIFICITY; FEMALE; GENETIC TRANSFECTION; GENETICS; LUMINESCENCE; METABOLISM; MOLECULAR IMAGING; MOUSE; PATHOLOGY; PROCEDURES; SIGNAL TRANSDUCTION; XENOGRAFT;

ANIMALS; BREAST NEOPLASMS; CELL LINE; DISEASE PROGRESSION; FEMALE; HETEROGRAFTS; IMIDAZOLES; LUCIFERASES; LUCIFERASES, FIREFLY; LUMINESCENT MEASUREMENTS; MICE; MOLECULAR IMAGING; NEOPLASM TRANSPLANTATION; PYRAZINES; SIGNAL TRANSDUCTION; SUBSTRATE SPECIFICITY; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 84885143737     PISSN: 15353508     EISSN: None     Source Type: Journal    
DOI: 10.2310/7290.2013.00062     Document Type: Article

References (34)

1. Paulmurugan R, Gambhir S. Firefly luciferase enzyme fragment complementation for imaging in cells and living animals. Anal Chem 2005;77:1295-302, doi:10.1021/ac0484777.
2. Zhang L, Lee K, Bhojani M, et al. Molecular imaging of Akt kinase activity. Nat Med 2007;13:1114-9, doi:10.1038/nm1608.
3. Luker K, Gupta M, Steele J, et al. Imaging ligand-dependent activation of CXCR7 Neoplasia 2009;11:1022-35.
4. Liu H, Patel M, Prescher J, et al. Cancer stem cells from human breast tumors are involved in spontaneous metastases in orthotopic mouse models. Proc Natl Acad Sci U S A 2010;107: 18115-20, doi:10.1073/pnas.1006732107.
5. Niers J, Kerami M, Pike L, et al. Multimodal in vivo imaging and blood monitoring of intrinsic and extrinsic apoptosis. Mol Ther 2011;19:1090-6, doi:10.1038/mt.2011.17.
6. Tannous B, Kim D, Fernandez J, et al. Codon-optimized Gaussia luciferase cDNA for mammalian gene expression in culture and in vivo. Mol Ther 2005;11:435-43, doi:10.1016/j.ymthe.2004.10.016.
7. Luker K, Gupta M, Luker G. Bioluminescent CXCL12 fusion protein for cellular studies of CXCR4 and CXCR7. Biotechniques 2009;47:625-32, doi:10.2144/000113126.
8. Santos E, Yeh R, Lee J, et al. Sensitive in vivo imaging of T cells utilizing a membrane bound Gaussia princeps luciferase enzyme. Nat Med 2009;15:338-44, doi:10.1038/nm.1930.
9. Maguire C, Deliolanis N, Pike L, et al. Gaussia luciferase variant for high-throughput functional screening applications. Anal Chem 2009;81:7102-6, doi:10.1021/ac901234r.
10. Degeling M, Bovenberg MS, Lewandrowski G, et al. Directed molecular evolution reveals Gaussia luciferase variants with enhanced light output stability. Anal Chem 2013;85:3006-12, doi:10.1021/ac4003134.
11. Hall M, Unch J, Binkowski B, et al. Engineered luciferase reporter from a deep sea shrimp utilizing a novel imidazopyrazinone substrate. ACS Chem Biol 2012;7:1848-57, doi:10.1021/ cb3002478.
12. Nyati S, Schinske K, Ray D, et al. Molecular imaging of TGFbetainduced Smad2/3 phosphorylation reveals a role for receptor tyrosine kinases in modulating TGFbeta signaling. Clin Cancer Res 2011;17:7424-39, doi:10.1158/1078-0432.CCR-11-1248.
13. Luker K, Mihalko L, Schmidt B, et al. In vivo imaging of ligand receptor binding with Gaussia luciferase complementation. Nat Med 2012;18:172-7, doi:10.1038/nm.2590.
14. Lois C, Hong E, Pease S, et al. Germline transmission and tissuespecific expression of transgenes delivered by lentiviral vectors. Science 2002;295:868-72, doi:10.1126/science.1067081.
15. Smith M, Luker K, Garbow J, et al. CXCR4 regulates growth of both primary and metastatic breast cancer. Cancer Res 2004;64: 8604-12, doi:10.1158/0008- 5472.CAN-04-1844.
16. Abramoff M, Magalhaes P, Ram S. Image processing with ImageJ. Biophotonics Int 2004;11:36-42.
17. Zhang J, Lu Y, Dai J, et al. In vivo real-time imaging of TGF-betainduced transcriptional activation of the RANK ligand gene promoter in intraosseous prostate cancer. Prostate 2004;59:360- 9, doi:10.1002/pros.20019.
18. Mohammad K, Chen C, Balooch G, et al. Pharmacologic inhibition of the TGF-beta type I receptor kinase has anabolic and anti-catabolic effects on bone. PLoS One 2009;4:e5275, doi:10.1371/journal.pone.0005275.
19. Leung S, Niimi A, Noble A, et al. Effect of transforming growth factor-beta receptor I kinase inhibitor 2,4-disubstituted pteridine (SD-208) in chronic allergic airway inflammation and remodeling. J Pharmacol Exp Ther 2006;319:586-94, doi:10.1124/jpet.106.109314.
20. Mohammad K, Javelaud D, Fournier P, et al. TGF-beta-RI kinase inhibitor SD-208 reduces the development and progression of melanoma bone metastases. Cancer Res 2011;71:175-84, doi:10.1158/0008-5472.CAN-10-2651.
21. Luker G, Bardill J, Prior J, et al. Noninvasive bioluminescence imaging of herpes simplex virus type 1 infection and therapy in living mice. J Virol 2002;76:12149-61, doi:10.1128/JVI.76.23.12149-12161.2002.
22. Wurdinger T, Badr C, Pike L, et al. A secreted luciferase for ex vivo monitoring of in vivo processes. Nat Methods 2008;5:171-3, doi:10.1038/nmeth. 1177.
23. Massague J. TGFbeta in Cancer. Cell 2008;134:215-30.
24. Jonk L, Itoh S, Heldin C, et al. Identification and functional characterization of a Smad binding element (SBE) in the JunB promoter that acts as a transforming growth factor-beta, activin, and bone morphogenetic protein-inducible enhancer. J Biol Chem 1998;273:21145-52, doi:10.1074/jbc.273. 33.21145.
25. Zhang Y. Non-Smad pathways in TGF-beta signaling. Cell Res 2009;19:128-39, doi:10.1038/cr.2008.328.
26. Fan Q, He M, Sheng T, et al. Requirement of TGFbeta signaling for SMO-mediated carcinogenesis. J Biol Chem 2010;285:36570-6, doi:10.1074/jbc.C110. 164442.
27. Clements M, Pernaute B, Vella F, Rodriguez T. Crosstalk between Nodal/Activin and MAPK p38 signaling is essential for anteriorposterior axis specification. Curr Biol 2011;21:1289-95, doi:10. 1016/j.cub.2011.06.048.
28. van Rijn S, Nilsson J, Noske D, et al. Functional multiplex reporter assay using tagged Gaussia luciferase. Sci Rep 2013;3:1046, doi:10.1038/ srep01046.
29. Massagué J. TGFb signalling in context. Nat Rev Mol Cell Biol 2012;13:616-30, doi:10.1038/nrm3434.
30. Akhurst R, Hata A. Targeting the TGFb signalling pathway in disease. Nat Rev Drug Discov 2012;11:790-811, doi:10.1038/ nrd3810.
31. Loening A, Wu A, Gambhir S. Red-shifted Renilla reniformis luciferase variants for imaging in living subjects. Nat Methods 2007;4:641-3, doi:10.1038/nmeth1070.
32. Kim S, Suzuki H, Sato M, Tao H. Superluminescent variants of marine luciferases for bioassays. Anal Chem 2011;83:8732-40, doi:10.1021/ac2021882.
33. Song G, Jiang Q, Xu T, et al. A convenient luminescence assay of ferroportin internalization to study its interaction with hepcidin. FEBS J 2013;280:1773-81, doi:10.1111/febs.12192.
34. Venisnik K, Olafsen T, Gambhir S, Wu A. Fusion of Gaussia luciferase to an engineered anti-carcinoembryonic antigen (CEA) antibody for in vivo optical imaging. Mol Imaging Biol 2007;9: 267-77, doi:10.1007/s11307-007-0101-8.